Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Phase of Trial: Phase I/II
Latest Information Update: 04 Jul 2017
At a glance
- Drugs SP 0173 (Primary) ; Diphtheria tetanus and pertussis vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors sanofi pasteur
- 28 Jun 2017 Status changed from active, no longer recruiting to completed.
- 17 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 22 Apr 2016 Status changed from active, no longer recruiting to recruiting.